Abstract
From its first introduction as a therapeutic agent for IC in 1963 on treatment results of heparin use have been rarely but constantly reported until today. The preferred route of administration is by intravesical instillation although patients suffering from bladder pain syndrome often fear and wish to avoid repetitive catheterization. Thus, the subcutaneous route of administration as reported for the first time by Gunnar Lose in 1983 and summarized in Chap. 15 in the first edition of this book, offers an alternative, less painful and minimal invasive approach. However, in contrast to subcutaneous administration which requires the monitoring of clotting parameters, no such information is required for the safe use of instillations which increases their feasibility regarding follow up monitoring of patients and has added to their preference as a mode of administration.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baykal K, Senkul T, Sen B, Karademir K, Adayener C, Erden D. Intravesical heparin and peripheral neuromodulation on interstitial cystitis. Urol Int. 2005;74(4):361–4.
Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J Formos Med Assoc. 2001;100(5):309–14.
Nomiya A, Naruse T, Niimi A, et al. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol. 2013;20(11):1118–22.
Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65(1):45–8.
Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73(5):504–7.
Parsons CL, Koziol JA, Proctor JG, Zupkas P, Argade S. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol. 2015;22(2):7739–44.
Parsons CL, Zupkas P, Proctor J, et al. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J Sex Med. 2012;9(1):207–12.
Taneja R, Jawade KK. A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis. Scand J Urol Nephrol. 2007;41(6):511–5.
van Ophoven A, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis. Urology. 2005;66(4):707–11.
Weaver RG, Dougherty TF, Natoli CA. Recent concepts of interstitial cystitis. J Urol. 1963;89:377–83.
Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology. 2008;71(1):67–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
van Ophoven, A. (2018). The Use of Heparin. In: Hanno, P., Nordling, J., Staskin, D., Wein, A., Wyndaele, J. (eds) Bladder Pain Syndrome – An Evolution. Springer, Cham. https://doi.org/10.1007/978-3-319-61449-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-61449-6_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61448-9
Online ISBN: 978-3-319-61449-6
eBook Packages: MedicineMedicine (R0)